Drug safety notice: Zopiclone tablets

September 22, 2020

Ratiopharm and Generics have informed us that the leaflet within all packs of Zopiclone tablets and the summary of product characteristics (SPC) for Ratiopharm is missing important safety information related to potential suicide risks.

The missing information can be found by clicking here.

All clinical colleagues should be aware of defect information.

Note: All stock currently held in pharmacy is not from the affected brands.

For more information please contact the pharmacy department (City ext. 5263, Sandwell ext. 3783).